Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.

by Ferdows Ather, Habib Hamidi, Marlena S Fejzo, Stephen Letrent, Richard S Finn, Fairooz Kabbinavar, Christian Head, Steven G Wong
Published 2013-01-01

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

by Dennis J. Slamon, Richard S. Finn, Gottfried E. Konecny, Michael J. Haykinson, Nuraly K. Avliyakulov, Ondrej Kalous, Erika M. von Euw, Lee Anderson, Marlena S. Fejzo
Published 2013-02-01

Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum

by Marlena S. Fejzo, Olga V. Sazonova, J. Fah Sathirapongsasuti, Ingileif B. Hallgrímsdóttir, Vladimir Vacic, Kimber W. MacGibbon, Frederic P. Schoenberg, Nicholas Mancuso, Dennis J. Slamon, Patrick M. Mullin, 23andMe Research Team
Published 2018-03-01